SCHEMBL7969898

SCHEMBL7969898

O=[N+]([O-])c1cccc2nc(Nc3c(Cl)cc(Cl)cc3Cl)c3cncn3c12

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982922 0.93 LCK (0.75) LCK
SCHEMBL7980776 0.93 LCK (0.77) LCK
SCHEMBL7983709 0.92 LCK (0.70) LCK
SCHEMBL7970327 0.92 LCK (0.76) LCK
SCHEMBL7986996 0.89 LCK (0.69) LCK
SCHEMBL7981173 0.88 LCK (0.65) LCK
SCHEMBL7979850 0.88 LCK (0.75) LCK
SCHEMBL7987777 0.86 LCK (0.73) LCK
SCHEMBL7969678 0.85 LCK (0.66) LCK
SCHEMBL7979688 0.84 LCK (0.68) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed